InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

TransMedics Group, Inc.

TMDX Clue Score83
United States Fiscal year ends December CIK 0001756262 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

21
Insider
Date
Role
Action
Shares
Price
Amount
Edward M Basile
7 May 2024
Director
Sold on a plan
816
$132.34
$107.99K
Edward M Basile
7 May 2024
Director
Sold on a plan
1,100
$131.34
$144.47K
Edward M Basile
7 May 2024
Director
Sold on a plan
885
$130.31
$115.32K
Edward M Basile
7 May 2024
Director
Sold on a plan
2,226
$129.80
$288.93K
Edward M Basile
7 May 2024
Director
Sold on a plan
2,130
$128.43
$273.56K
James R Tobin
3 May 2024
Director
Sold on a plan indirect
6,895
$125.26
$863.67K
James R Tobin
3 May 2024
Director
Sold on a plan indirect
5,130
$124.76
$640.02K
Waleed H Hassanein
2 May 2024
President & CEO
Sold on a plan
82
$122.67
$10.06K
Waleed H Hassanein
2 May 2024
President & CEO
Sold on a plan
6,222
$122.16
$760.08K
Waleed H Hassanein
2 May 2024
President & CEO
Sold on a plan
6,140
$120.64
$740.73K
James R Tobin
1 May 2024
Director
Sold on a plan indirect
2,000
$110.00
$220.00K
James R Tobin
1 May 2024
Director
Sold on a plan indirect
100
$108.47
$10.85K
James R Tobin
1 May 2024
Director
Sold on a plan indirect
1,704
$106.89
$182.14K
James R Tobin
1 May 2024
Director
Sold on a plan indirect
11,236
$105.70
$1.19M
James R Tobin
1 Mar 2024
Director
Sold on a plan indirect
300
$85.48
$25.64K
James R Tobin
1 Mar 2024
Director
Sold on a plan indirect
2,900
$84.74
$245.75K
James R Tobin
1 Mar 2024
Director
Sold on a plan indirect
5,746
$83.63
$480.54K
James R Tobin
1 Mar 2024
Director
Sold on a plan indirect
4,234
$82.84
$350.74K
James R Tobin
1 Mar 2024
Director
Sold on a plan indirect
200
$81.41
$16.28K
Edward M Basile
6 Feb 2024
Director
Sold on a plan
1,384
$86.83
$120.17K
Edward M Basile
6 Feb 2024
Director
Sold on a plan
5,773
$86.27
$498.04K
Showing 250 of 441 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 329
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 21
Sales straight out of an exercise 304
Sales at will 85
Transactions with no price 0
Shares from compensation/vesting 21,489,838
Sales filed before the plan box existed 46
History held since 6 May 2019